山东新华制药股份(00719)建议委任致同为新核数师

Core Viewpoint - Shandong Xinhua Pharmaceutical Co., Ltd. has appointed a new auditor, Crowe Horwath, for the fiscal year ending December 31, 2024, following an independent evaluation process by its audit committee [1] Group 1 - The audit committee conducted an independent and objective assessment of the selection process, tendering procedures, and the professional competence, capability, integrity, and independence of the proposed auditing firm [1] - The audit committee concluded that Crowe Horwath is qualified and suitable to serve as the company's auditor for the specified period [1] - The board of directors has resolved to recommend the appointment of Crowe Horwath as the new auditor based on the audit committee's suggestions [1]